The neuronal growth cone, a chemotactic nerve ending, navigates the axon along the correct path by sensing extracellular guidance cues 1,2. It is well known that localized Ca 2+ signals in the growth ...

Axon guidance pathway is one of the critical processes related to connectivity and repair of the wiring of the brain during the central nervous system development and throughout the lifetime in humans ...

Axon Enterprises (NASDAQ:AXON) +17.9% in Wednesday's trading to top the S&P 500 leaderboard after routing Q4 adjusted earnings expectations and providing an update that included strong bookings and a ...

Axon Enterprise, Inc. is rated Strong Buy with strong moat, robust growth prospects and AI implementation. Learn more about ...

Axon Enterprise recently raised its full-year 2025 earnings guidance, reflecting strong growth expectations with a revised revenue range of $2.6 to $2.7 billion. Despite this optimistic outlook, the ...

Axon Enterprise Inc. (NASDAQ:AXON) reported its fourth-quarter results after Tuesday's closing bell. Here's a look at the details from the report. The Details: Axon Enterprise reported quarterly ...

ING3 as a novel regulator of pancreatic cancer growth and aggressiveness. Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer ...

Axon Enterprise Inc (NASDAQ:AXON) shares are rising in after-hours Wednesday after the company beat first-quarter estimates and raised its full-year guidance. Q1 Earnings: Axon reported first-quarter ...

Axon Enterprise Inc. (NASDAQ:AXON) shares surged during Tuesday’s regular session after multiple analysts raised their price forecasts following the company’s strong second-quarter results and ...

Axon Enterprise, Inc. AXON reported third-quarter 2023 earnings (excluding 7 cents from non-recurring items) of 71 cents per share. The bottom line increased significantly year over year despite a ...

Axon Enterprise, Inc. AXON reported second-quarter 2025 adjusted earnings of $2.12 per share, which surpassed the Zacks Consensus Estimate of $1.54. The bottom line surged 73.8% year over year despite ...